Sai Life Sciences Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27Q4 FY26 — transcript filed; not yet summarised
Q1 FY27 earnings call
Sai Life Sciences reported Q1 FY27 revenue of INR553 crores, up about 12% year-over-year, with CRO revenue growing 26% and CDMO growing about 6%. Management said the quarter's performance was in line with expectations and reiterated confidence in a stronger second half driven by planned capacity expansion. The company discussed progress on peptides, XDC, formulation and AI initiatives, and reaffirmed its longer-term revenue growth and EBITDA margin guidance.